1-7 of 7
Jack T Seki
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Which Asparaginase Formulation Retained Higher VTE Incidence Risk in Post Treatment Adult Acute Lymphoblastic Leukemia? a Meta-Analysis

Jack T Seki, Reem Alsibai, Ruiqi Chen, Eshetu G. Atenafu, Hassan Sibai
Journal: Blood
Blood (2022) 140 (Supplement 1): 8898–8899.
https://doi.org/10.1182/blood-2022-167560
Published: 2022
Journal Articles

A Retrospective Study of Venous Thromboembolism in Acute Leukemia Patients during Prolonged Hospital Stay. the Princess Margaret Cancer Centre Experience

Hassan Sibai, MD, Umberto Falcone, MD PhD, Arjun Datt Law, MBBS,MDDM, Ali Hosni, MD, Carmen Tan, Naoko Sakurai, Phm, MSc, Andre C. Schuh, MD FRCPC, Mark D. Minden, MD PhD, Steven M. Chan, MD PhD, Karen W.L. Yee, MD, Vikas Gupta, MD FRCP, FRCPath, Aaron D. Schimmer, MD PhD, Jack T Seki, PharmD
Journal: Blood
Blood (2016) 128 (22): 2615.
https://doi.org/10.1182/blood.V128.22.2615.2615
Published: 2016
Journal Articles

Anticoagulation Prophylaxis in Asparaginase-Based Therapy in Adults with Acute Lymphoblastic Leukemia

Hassan Sibai, MD, Umberto Falcone, MD PhD, Arjun Datt Law, MBBS,MDDM, Naoko Sakurai, Phm, MSc, Lalit Saini, MD, Tian Q Wang, Andrew Stessman, Joseph Samuel, Eshetu G. Atenafu, Ali Hosni, MD, Andre C. Schuh, MD FRCPC, Karen W.L. Yee, MD, Vikas Gupta, MD FRCP, FRCPath, Mark D. Minden, MD PhD, Steven M. Chan, MD PhD, Aaron D. Schimmer, MD PhD, Joseph M. Brandwein, MD FRCPC, Jack T Seki, PharmD
Journal: Blood
Blood (2016) 128 (22): 1453.
https://doi.org/10.1182/blood.V128.22.1453.1453
Published: 2016
Journal Articles

A Rapid Desensitization Program Is a Viable Therapeutic Option in the Management of Immunomodulating Agent-Related Hypersensitivity Reactions in Patients with Plasma Cell Disorders

Jack T Seki, PharmD, Naoko Sakurai, Phm, MSc, Wallace Lam, BSc, Phm, Vesna Lukaroska, BSc, Phm, Anna Granic, BSc, Phm, Patricia Disperati, MD, Amy Tam, MD, Suzanne Trudel, MD, Donna Reece, MD
Journal: Blood
Blood (2016) 128 (22): 2411.
https://doi.org/10.1182/blood.V128.22.2411.2411
Published: 2016
Journal Articles

A Phase II Study Of Aprepitant As Anti-Emetic Prophylaxis In Patients Receiving Induction Chemotherapy For AML

Joseph Brandwein, MD, FRCPC, Karen W.L. WL Yee, MD, Andre C Schuh, MD, Vikas Gupta, MD, FRCP, FRCPath, Jack T Seki, PharmD
Journal: Blood
Blood (2013) 122 (21): 5035.
https://doi.org/10.1182/blood.V122.21.5035.5035
Published: 2013
Journal Articles

Anticoagulation Prophylaxis With Enoxaparin For Patients With Acute Lymphoblastic Leukemia Receiving Asparaginase-Based Intensification Therapy

Hassan Sibai, Jack T Seki, PharmD, Eshetu G Atenafu, MSc, Karen W.L. Yee, MD, FRCP, Andre C Schuh, MD, Vikas Gupta, MD, FRCP, FRCPath, Mark D. Minden, MD, PhD, Aaron D. Schimmer, MD, PhD, Joseph M. Brandwein, MD
Journal: Blood
Blood (2013) 122 (21): 2636.
https://doi.org/10.1182/blood.V122.21.2636.2636
Published: 2013
Journal Articles

Thrombotic Events in Adults with Acute Lymphoblastic Leukemia.

Christine M. Cserti, MD, Joseph Brandwein, MD, Jeffrey H. Lipton, MD, PhD, Anne G. McLeod, MD, Hans Messner, MD, PhD, Mark D. Minden, MD, PhD, Aaron D. Schimmer, MD, PhD, Andre C. Schuh, MD, PhD, Jack T. Seki, PharmD, Erik L. Yeo, MD, Qi-Long Yi, PhD, Richard A. Wells, MD, DPhil
Journal: Blood
Blood (2004) 104 (11): 2734.
https://doi.org/10.1182/blood.V104.11.2734.2734
Published: 2004